Elecsys IGFBP-3

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

• Intended use Immunoassay for the in vitro quantitative determination of insulin‑like growth factor binding protein‑3 (IGFBP‑3) in human serum and plasma. The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e…

  Roche DiagnosticsCategory L2Manufacturer Page2026-10-06

• The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “EC

  Roche DiagnosticsCategory L1Manufacturer Page2026-10-06